ractopamine has been researched along with Atherosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Chen, WH; Guo, BC; Hsu, MC; Hu, HY; Hu, PA; Lee, HT; Lee, TS | 1 |
1 other study(ies) available for ractopamine and Atherosclerosis
| Article | Year |
|---|---|
Ractopamine at legal residue dosage accelerates atherosclerosis by inducing endothelial dysfunction and promoting macrophage foam cell formation.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Endothelial Cells; Foam Cells; Humans; Inflammation; Lipoproteins, LDL; Macrophages; Mice; Phenethylamines | 2022 |